⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17654291 | 0.77 | — | — | |
| SCHEMBL17654318 | 0.69 | — | — | |
| SCHEMBL15414793 | 0.65 | HTR1A (0.31) | — | |
| SCHEMBL15415995 | 0.62 | — | — | |
| SCHEMBL15415568 | 0.60 | — | — | |
| SCHEMBL15415327 | 0.60 | MAOA (0.38) | — | |
| SCHEMBL15415112 | 0.60 | — | — | |
| SCHEMBL15415840 | 0.59 | — | — | |
| SCHEMBL16793386 | 0.58 | — | — | |
| SCHEMBL16793388 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912721-B2 | Fused pentacyclic imidazole derivatives | UCB Biopharma SRL (BE) | 2024-02-27 | — | — | US | disclosed |
| EP-3436456-B1 | FUSED HEXACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SRL (BE) | 2021-11-17 | — | — | EP | disclosed |
| EP-3436460-B1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SRL (BE) | 2021-08-18 | — | — | EP | disclosed |
| EP-3201196-B1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES | UCB Biopharma SRL (BE) | 2021-07-28 | — | — | EP | disclosed |
| EP-3436458-B1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SRL (BE) | 2021-06-02 | — | — | EP | disclosed |
| US-20210155637-A1 | Fused Pentacyclic Imidazole Derivatives | SANOFI (FR) | 2021-05-27 | — | — | US | disclosed |
| US-10953019-B2 | Fused pentacyclic imidazole derivatives as modulators of TNF activity | UCB Biopharma SRL (BE) | 2021-03-23 | — | — | US | disclosed |
| US-10906919-B2 | Fused pentacyclic imidazole derivatives | UCB Biopharma SRL (BE) | 2021-02-02 | — | — | US | disclosed |
| US-10793578-B2 | Fused pentacyclic imidazole derivatives as modulators of TNF activity | UCB Biopharma SRL (BE) | 2020-10-06 | — | — | US | disclosed |
| US-10766906-B2 | Fused hexacyclic imidazole derivatives as modulators of TNF activity | UCB Biopharma SRL (BE) | 2020-09-08 | — | — | US | disclosed |
| EP-3436458-A1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SPRL (BE) | 2019-02-06 | — | — | EP | disclosed |
| EP-3436460-A1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SPRL (BE) | 2019-02-06 | — | — | EP | disclosed |
| EP-3436459-A1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SPRL (BE) | 2019-02-06 | — | — | EP | disclosed |
| WO-2018167176-A1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL (BE) | 2018-09-20 | — | — | WO | disclosed |
| US-20170305932-A1 | Fused Pentacyclic Imidazole Derivatives | SANOFI (FR) | 2017-10-26 | — | — | US | disclosed |
| WO-2017167993-A1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL (BE) | 2017-10-05 | — | — | WO | disclosed |
| WO-2017167996-A1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL (BE) | 2017-10-05 | — | — | WO | disclosed |
| WO-2017167994-A1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL (BE) | 2017-10-05 | — | — | WO | disclosed |
| EP-3201196-A1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES | UCB Biopharma SPRL (BE) | 2017-08-09 | — | — | EP | disclosed |
| WO-2016050975-A1 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES | UCB BIOPHARMA SPRL (BE) | 2016-04-07 | — | — | WO | disclosed |